Abstract |
The ganglioside composition of the brain from an individual with classical Tay-Sachs disease and from an individual with Sandhoff disease was examined using our new quantitative methods for ganglioside content determination and compared with that of age-matched control brains. The concentration of GM2 was found to be 12.2 and 13.0 mumol/g of fresh tissue in Tay-Sachs disease and in Sandhoff disease cerebral gray matter, respectively. GM2 was 86 and 87% respectively, of total gangliosides. The concentration of GM1 and, in particular, GM3 ganglioside was also found to be increased, whereas the concentration of the major di- and trisialogangliosides (GD1a, GD1b, and GT1b) had diminished markedly. There was no significant increase in level of any other ganglioside than lyso-GM2. Its concentration was 12 and 16 nmol/g in cerebral gray matter of two Tay-Sachs disease brains and 43 nmol/g in Sandhoff disease brain. The Sandhoff disease brain also differed from the classical Tay-Sachs disease brain by having a much higher concentration of gangliotriaosylceramide and globotetraosylceramide. The structures of relevant gangliosides and neutral glycolipids were established by fast atom bombardment-mass spectrometry and permethylation studies.
|
Authors | B Rosengren, J E Månsson, L Svennerholm |
Journal | Journal of neurochemistry
(J Neurochem)
Vol. 49
Issue 3
Pg. 834-40
(Sep 1987)
ISSN: 0022-3042 [Print] England |
PMID | 3612128
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Gangliosides
- Glycosphingolipids
- Lactosylceramides
- lysoganglioside G(M2)
- G(M2) Ganglioside
- lactotriaosylceramide
|
Topics |
- Brain Chemistry
- Child, Preschool
- Chromatography, Thin Layer
- Female
- Fetus
(analysis)
- G(M2) Ganglioside
(analogs & derivatives, analysis)
- Gangliosides
(analysis)
- Glycosphingolipids
(analysis)
- Humans
- Lactosylceramides
(analysis)
- Male
- Mass Spectrometry
- Sandhoff Disease
(metabolism)
- Tay-Sachs Disease
(metabolism)
|